|
| 36690537 | Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic graft-versus-host disease or relapse rates. | Cytotherapy | 2023 |
| 37664800 | A new beginning: can omidubicel emerge as the next, viable alternative donor source? | Ther Adv Hematol | 2023 |
| 36441905 | Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia. | Blood Adv | 2023 |
| 35443022 | Transplant outcomes after CPX-351 vs 7â¿¿+â¿¿3 in older adults with newly diagnosed high-risk and/or secondary AML. | Blood Adv | 2022 |
| 34171279 | CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial. | Lancet Haematol | 2021 |
| 33901720 | Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse. | Transplant Cell Ther | 2021 |
| 34889409 | Acute GVHD: think before you treat. | Hematology Am Soc Hematol Educ Program | 2021 |
| 34615640 | Advances in acute myeloid leukemia. | BMJ | 2021 |
| 33961341 | Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations. | Am J Transplant | 2021 |
| 33020547 | Diurnal stability of cell-free DNA and cell-free RNA in human plasma samples. | Sci Rep | 2020 |
| 31715306 | Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation. | Biol Blood Marrow Transplant | 2020 |
| 31085121 | Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors. | Cytotherapy | 2019 |
| 31098682 | A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias. | Cancer Chemother Pharmacol | 2019 |
| 30836091 | Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged â¿¥70 years. | Hematol Oncol Stem Cell Ther | 2019 |
| 29058696 | Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402. | Bone Marrow Transplant | 2018 |
| 30024784 | CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia. | J Clin Oncol | 2018 |
| 30087106 | Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802. | Blood Adv | 2018 |
| 27869812 | Low day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation. | Bone Marrow Transplant | 2017 |
| 28355571 | Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia. | Cell Rep | 2017 |
| 28635072 | PlGF enhances TLR-dependent inflammatory responses in human mononuclear phagocytes. | Am J Reprod Immunol | 2017 |
| 28581470 | Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402. | Bone Marrow Transplant | 2017 |
| 27608972 | Placental growth factor: What hematologists need to know. | Blood Rev | 2017 |
| 27020088 | Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells. | Blood | 2016 |
| 26573090 | Mutant calreticulin-expressing cells induce monocyte hyperreactivity through a paracrine mechanism. | Am J Hematol | 2016 |
| 27625357 | Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors. | Blood | 2016 |
| 25759146 | Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802. | Biol Blood Marrow Transplant | 2015 |
| 25961774 | Chronic GvHD-associated serositis and pericarditis. | Bone Marrow Transplant | 2015 |
| 25650090 | Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy. | Leukemia | 2015 |
| 24397853 | Adult adherent stromal cells in the management of graft-versus-host disease. | Expert Opin Biol Ther | 2014 |
| 25221674 | Impact of clinical factors and allograft leukocyte content on post-transplant lymphopenia, monocytopenia, and survival in patients undergoing allogeneic peripheral blood haematopoietic cell transplant. | BMC Hematol | 2014 |
| 23584444 | Characteristics of chronic GVHD after cord blood transplantation. | Bone Marrow Transplant | 2013 |
| 23981727 | Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis. | Stem Cells Transl Med | 2013 |
| 21840290 | Stable long-term pulmonary function after myeloablative double cord blood transplant. | Biol Blood Marrow Transplant | 2012 |
| 22326302 | Early CD3 peripheral blood chimerism predicts the long-term engrafting unit following myeloablative double-cord blood transplantation. | Biol Blood Marrow Transplant | 2012 |
| 20541027 | Tumor necrosis factor polymorphism affects transplantation outcome in patients with myelodysplastic syndrome but not in those with chronic myelogenous leukemia, independent of the presence of HLA-DR15. | Biol Blood Marrow Transplant | 2010 |
| 18021260 | Complementary roles for histone deacetylases 1, 2, and 3 in differentiation of pluripotent stem cells. | Differentiation | 2008 |
| 12796477 | BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. | J Cell Biol | 2003 |